You're Training Hard, Yet Still Can't Keep Up. Here's Why.

SOD2 encodes the enzyme superoxide dismutase 2, which sits inside your mitochondria and neutralizes free radicals before they damage the machinery that produces ATP. It’s your cells’ first line of defense against oxidative stress, and it’s especially critical during intense exercise when free radical production spikes.

The Val16Ala variant at rs4880 is present in roughly 40% of people with European ancestry in the homozygous form. The Ala variant produces less active MnSOD, meaning your mitochondria accumulate oxidative damage faster during and after training. This is particularly true if you do high-intensity interval training, where free radical production skyrockets.

You notice this as slower recovery between hard sessions, worse delayed-onset muscle soreness (DOMS), and a longer time before you feel genuinely strong again. A single hard workout leaves you depleted for days. Your muscles feel sore and heavy even when you’re well-rested. You recover better from light activity but struggle to push intensity repeatedly.

MTHFR is the methylenetetrahydrofolate reductase enzyme, which converts dietary folate and B vitamins into the usable forms your cells actually need. This includes converting homocysteine (a toxic byproduct) into harmless methionine. The entire process fuels ATP production and red blood cell formation.

The C677T variant, carried by approximately 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40-70%. That means your body accumulates homocysteine and struggles to produce enough functional red blood cells. Elevated homocysteine stiffens your blood vessels, impairing oxygen delivery to working muscles during aerobic exercise. Your red blood cells also carry less oxygen per cell because the B vitamin conversion is incomplete.

During a hard run or cycling session, you hit a wall sooner than athletes without this variant. Your aerobic capacity feels lower than it should be. You feel the oxygen debt faster. Your VO2max doesn’t improve the way it does for your training partners, even though you’re putting in the same work. Climbing hills is disproportionately hard.

VDR encodes the vitamin D receptor, the protein that allows your cells to actually use the vitamin D circulating in your blood. Vitamin D is far more than a bone nutrient; it’s critical for muscle protein synthesis, calcium signaling during contraction, and mitochondrial biogenesis (making new mitochondria). Without functional VDR signaling, your muscles cannot repair or adapt efficiently.

The BsmI, FokI, and TaqI variants are common, present in roughly 30-50% of the population depending on ancestry. Certain genotypes reduce the sensitivity of your cells to vitamin D signaling. Even if your serum vitamin D is normal on a blood test, your muscles may not be receiving the signal to build protein or adapt to training. The problem is not the vitamin D in your blood; it’s your cells’ ability to respond to it.

After hard workouts, your muscles feel persistently weak or don’t firm up the way they should. You notice slower strength gains despite consistent training. Your endurance may also stall because mitochondrial biogenesis is impaired, limiting your aerobic capacity ceiling. Recovery feels sluggish even with adequate sleep and protein.

ADRB2 encodes the beta-2 adrenergic receptor, the protein on your fat cells that responds to adrenaline and noradrenaline during exercise. When you start training, your nervous system releases catecholamines to signal fat cells to break down stored triglycerides and release them into the bloodstream as fuel. ADRB2 is the lock that catecholamines need to open.

The Gln27Glu and Arg16Gly variants are common, affecting roughly 40% of the population. Certain genotypes reduce your fat cells’ sensitivity to catecholamine signaling. Even though your nervous system is telling your fat cells to release fuel, they don’t listen as well, so less fat enters your bloodstream during exercise. Your body is forced to rely more heavily on carbohydrate stores, which deplete much faster than fat stores.

You notice this as hitting the wall sooner on long endurance efforts, especially in a fasted state or early morning. You cannot sustain steady-state aerobic efforts as long as athletes with normal fat mobilization. Your body composition also responds slower to training; even with consistent exercise and diet, fat loss is stubborn. You may also feel like you bonk harder after carbohydrate depletion, because fat mobilization cannot compensate.

PPARGC1A encodes PGC-1 alpha, often called the master regulator of mitochondrial biogenesis. When you do endurance exercise, your muscles sense the energy demand and activate PGC-1 alpha to trigger the construction of new mitochondria. More mitochondria means more ATP production capacity and higher aerobic power. This is how endurance training makes you fitter.

The Gly482Ser variant at rs8192678 is present in roughly 35-40% of the population. The Ser variant produces less active PGC-1 alpha, meaning your muscles receive a weaker signal to build new mitochondria in response to endurance training. You’re doing the aerobic work, but your muscles are building fewer new mitochondria per unit of training stimulus. The adaptation simply happens slower and reaches a lower ceiling.

You notice this as a plateau in your aerobic capacity that feels disproportionately low for the volume of endurance work you’re putting in. Your VO2max gains are slower and smaller than your training partners’. An increase in mileage or intensity doesn’t translate into improved race times or endurance performance the way it should. You may also feel like your aerobic fitness is fragile; when you take even a short break from training, your aerobic capacity drops noticeably.

ACTN3 encodes alpha-actinin-3, a structural protein that anchors contractile machinery in your fast-twitch muscle fibers. Fast-twitch fibers are the ones that generate explosive power, rapid acceleration, and high force quickly. Athletes with functional ACTN3 have robust fast-twitch fiber architecture optimized for power sports.

The R577X variant at rs1815739 is common; the X/X (null) genotype, present in roughly 18% of people with European ancestry, produces no functional ACTN3 protein at all. People with the null genotype have reduced structural support in their fast-twitch fibers, limiting explosive power and peak force production. However, they often have a relatively better-preserved endurance profile because their muscle fiber distribution shifts toward slow-twitch oxidative fibers.

If you have the null genotype, you notice this as a much lower ceiling for explosive movements, sprinting, or power sports. You cannot generate the same peak force or acceleration as athletes with functional ACTN3. However, you may find steady-state endurance efforts more natural. You excel at long, moderate-intensity efforts but struggle with sprints or plyometric power. Your strength training also plateaus sooner for explosive movements, even with perfect programming.